Removing dosing guidance from a guideline summary takes a valuable tool from prescribers, says Dr. Mark Sullivan and pain-medicine colleagues.
A study published March 30 by the Centers for Disease Control and Prevention found that attention-deficit/hyperactivity disorder diagnoses and sti
Researchers call for more study after report confirms suspected spike in stimulant prescriptions among women during pandemic.
